These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10882596)

  • 1. Enterotoxin adjuvants have direct effects on T cells and antigen-presenting cells that result in either interleukin-4-dependent or -independent immune responses.
    Yamamoto M; Kiyono H; Kweon MN; Yamamoto S; Fujihashi K; Kurazono H; Imaoka K; Bluethmann H; Takahashi I; Takeda Y; Azuma M; McGhee JR
    J Infect Dis; 2000 Jul; 182(1):180-90. PubMed ID: 10882596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically manipulated bacterial toxin as a new generation mucosal adjuvant.
    Yamamoto M; McGhee JR; Hagiwara Y; Otake S; Kiyono H
    Scand J Immunol; 2001 Mar; 53(3):211-7. PubMed ID: 11251876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity.
    Ryan EJ; McNeela E; Pizza M; Rappuoli R; O'Neill L; Mills KH
    J Immunol; 2000 Nov; 165(10):5750-9. PubMed ID: 11067933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production.
    Brereton CF; Sutton CE; Ross PJ; Iwakura Y; Pizza M; Rappuoli R; Lavelle EC; Mills KH
    J Immunol; 2011 May; 186(10):5896-906. PubMed ID: 21490151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells.
    Martin M; Hajishengallis G; Metzger DJ; Michalek SM; Connell TD; Russell MW
    Infect Immun; 2001 Jan; 69(1):252-61. PubMed ID: 11119513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of B7 costimulatory molecules in the adjuvant activity of the heat-labile enterotoxin of Escherichia coli.
    Martin M; Sharpe A; Clements JD; Michalek SM
    J Immunol; 2002 Aug; 169(4):1744-52. PubMed ID: 12165495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit.
    Boyaka PN; Ohmura M; Fujihashi K; Koga T; Yamamoto M; Kweon MN; Takeda Y; Jackson RJ; Kiyono H; Yuki Y; McGhee JR
    J Immunol; 2003 Jan; 170(1):454-62. PubMed ID: 12496431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response.
    Fromantin C; Jamot B; Cohen J; Piroth L; Pothier P; Kohli E
    J Virol; 2001 Nov; 75(22):11010-6. PubMed ID: 11602741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct cytokine regulation by cholera toxin and type II heat-labile toxins involves differential regulation of CD40 ligand on CD4(+) T cells.
    Martin M; Metzger DJ; Michalek SM; Connell TD; Russell MW
    Infect Immun; 2001 Jul; 69(7):4486-92. PubMed ID: 11401990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28.
    Ryan M; McCarthy L; Rappuoli R; Mahon BP; Mills KH
    Int Immunol; 1998 May; 10(5):651-62. PubMed ID: 9645613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholera toxin and Escherichia coli heat-labile enterotoxin, but not their nontoxic counterparts, improve the antigen-presenting cell function of human B lymphocytes.
    Negri DR; Pinto D; Vendetti S; Patrizio M; Sanchez M; Riccomi A; Ruggiero P; Del Giudice G; De Magistris MT
    Infect Immun; 2009 May; 77(5):1924-35. PubMed ID: 19223474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunization with the B subunit of the heat-labile enterotoxin of Escherichia coli induces early Th1 and late Th2 cytokine expression in Peyer's patches.
    Nakagawa I; Takahashi I; Kiyono H; McGhee JR; Hamada S
    J Infect Dis; 1996 Jun; 173(6):1428-36. PubMed ID: 8648216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
    Schweitzer AN; Sharpe AH
    J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.
    Takahashi I; Marinaro M; Kiyono H; Jackson RJ; Nakagawa I; Fujihashi K; Hamada S; Clements JD; Bost KL; McGhee JR
    J Infect Dis; 1996 Mar; 173(3):627-35. PubMed ID: 8627026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
    Ryan EJ; McNeela E; Murphy GA; Stewart H; O'hagan D; Pizza M; Rappuoli R; Mills KH
    Infect Immun; 1999 Dec; 67(12):6270-80. PubMed ID: 10569737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability.
    Rodríguez-Sosa M; Satoskar AR; Calderón R; Gomez-Garcia L; Saavedra R; Bojalil R; Terrazas LI
    Infect Immun; 2002 Jul; 70(7):3656-64. PubMed ID: 12065507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct effects on antigen-presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant.
    Yamamoto M; Kiyono H; Yamamoto S; Batanero E; Kweon MN; Otake S; Azuma M; Takeda Y; McGhee JR
    J Immunol; 1999 Jun; 162(12):7015-21. PubMed ID: 10358143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.
    Arrington J; Braun RP; Dong L; Fuller DH; Macklin MD; Umlauf SW; Wagner SJ; Wu MS; Payne LG; Haynes JR
    J Virol; 2002 May; 76(9):4536-46. PubMed ID: 11932419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.
    Nawar HF; Arce S; Russell MW; Connell TD
    Infect Immun; 2007 Feb; 75(2):621-33. PubMed ID: 17118982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR2-dependent modulation of dendritic cells by LT-IIa-B5, a novel mucosal adjuvant derived from a type II heat-labile enterotoxin.
    Lee CH; Masso-Welch P; Hajishengallis G; Connell TD
    J Leukoc Biol; 2011 Nov; 90(5):911-21. PubMed ID: 21791597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.